Relevant studies have found that using PBMCs from healthy donors can induce human CD8 + T cells to respond to MDK-expressing cancer cells in vitro; and due to its widespread expression in cancer tissue and its contribution to cancer development, MDK appears to be an attractive candidate for cancer vaccines [34]. Here, CD8A is linked to cancer.